AIM Vaccine Co., Ltd. Class H (HK:6660) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
AIM Vaccine Co., Ltd. has announced the re-designation of Mr. Jie ZHOU and Mr. Xin ZHOU from non-executive to executive Directors, as well as their appointment as executive presidents. The re-designation, effective from August 29, 2024, coincides with both individuals ceasing to be members of the audit committee and involves new service contracts without director fees. Their remuneration will be based on their new management roles, with details to be disclosed annually.
For further insights into HK:6660 stock, check out TipRanks’ Stock Analysis page.